Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0085437 (
bacterial meningitis
)
4,038
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Serum amyloid A protein
(
SAA
), a putative precursor of the AA protein which constitutes amyloid fibrils in secondary amyloidosis, is evaluated as a sensitive acute-phase reactant in serum. At present,
SAA
concentration in serum is determined by latex nephelometry, but this assay cannot detect
SAA
in the low concentration range lower than 10 ng/ml. We have developed a sensitive enzyme immunoassay (EIA) for determining low concentrations of
SAA
. The assay is reproducible, reliable and requires no pretreatment of specimen prior to assay. We measured levels of
SAA
by this EIA in both cerebrospinal fluid (CSF) and serum of patients with suspected meningitis, measured also levels of albumin, alpha 2 macroglobulin and C-reactive protein (CRP) to investigate if these protein levels are useful for differential diagnoses of meningitis and for indicators damage of blood-CSF barrier. The
SAA
reference value in CSF is 3.99 +/- 1.74 ng/ml (mean +/- SD for nonmeningitis patients). The CRP concentration in CSF in
bacterial meningitis
was much higher than in viral meningitis, but CRP in CSF was also high in bacterial infection other than meningitis. On the other hand,
SAA
concentration in CSF in these patients with any meningitis are significantly higher than the reference values of
SAA
(p < 0.001). However, the differences in
SAA
concentrations among the three types (bacterial, viral and mycotic meningitis) of meningitis were not significant.
...
PMID:[Quantitative levels of serum amyloid A protein and other proteins in cerebrospinal fluid and serum of patients with meningitis]. 980 Apr 79